Poster Session B - Monday Morning
Category: Interventional Endoscopy
Nicholas McDonald, MD
University of Minnesota
Minneapolis, MN
Indication | N = 21 patients |
Acute Cholecystitis | 18 (86%) |
Symptomatic Cholelithiasis | 3 (14%) |
Patient characteristics |
|
Female | 10 (48%) |
Age | 75 years (SD 12) |
Inpatient | 17 (81%) |
Chronic kidney disease | 3 (14%) |
Diabetes mellitus | 11 (52%) |
Cirrhosis | 1 (5%) |
Platelet count (K/cmm) | 247 (SD 64) |
INR | 1.2 (SD 0.22) |
Anticoagulation use Apixaban Enoxaparin
| 8 (38%) 7 (33%) 1 (5%) |
Procedure characteristics |
|
Site of Lumen Apposing Metal Stent placement Stomach Duodenum |
15 (71%) 6 (29%) |
Size of Lumen Apposing Metal Stent 10 mm x 10 mm 15 mm x 10 mm |
14 (67%) 7 (33%) |
Outcomes |
|
Technical success | 21 (100%) |
Clinical success | 21 (100%) |
Stent removed | 10 (48%; average 41 days) |
Recurrent Cholecystitis | 0 |
Length of follow-up (days, median) | 75 |
Adverse events |
|
Any adverse event | 2 (10%) |
Need for admission following procedure | 1 (5%) |
Post-procedural pain within 30-days | 1 (5%) |
Death within 30-days | 0 |